Guardant Health
GH
#1570
Rank
C$18.25 B
Marketcap
C$140.57
Share price
0.68%
Change (1 day)
177.40%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): C-$4.52

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is C-$4.42. In 2024 the company made an earnings per share (EPS) of C-$4.90 an increase over its 2023 EPS that were of C-$5.89.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$4.52-7.84%
2024C-$4.90-16.82%
2023C-$5.89-33.13%
2022C-$8.8160%
2021C-$5.5155.04%
2020C-$3.55207.14%
2019C-$1.16-19.81%
2018C-$1.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
C-$2.95-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
C-$6.62 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA